Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana

Table 3 ANC attendance and IPTp-SP uptake among study participants

Characteristics	Frequency (n = 255)	Percentage (%)
Gestational age at first ANC
First trimester	105	41.18
Second trimester	126	49.41
Third trimester	24	9.41
Number of ANC visits
<4	29	11.37
≥4	226	88.63
Number of doses received
None	3	1.18
One dose	10	3.92
Two doses	19	7.45
Three doses	81	31.76
Four doses	105	41.18
Five doses	37	14.51
Gestational age at first dose of SP
16	53	21.03
17–24	165	65.48
25–36	34	13.49
Number of SP tablets swallowed per dose during pregnancy
2	3	1.2
3	249	98.8
Place where SP was dispensed
ANC	250	99.21
Pharmacy	2	0.79
Stopped folic acid whiles taking SP drug
Did not stop	249	98.8
Stopped	3	1.2
Took SP drug under DOT
Not directly observed	2	0.8
Directly observed	250	99.2

n number of respondents, ANC antenatal centre, SP sulphadoxine pyrimethamine, DOT direct observed therapy

ISSN: 1475-2875